Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1999 Feb;64(2):495–507. doi: 10.1086/302260

Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population.

D C Crawford 1, K L Meadows 1, J L Newman 1, L F Taft 1, D L Pettay 1, L B Gold 1, S J Hersey 1, E F Hinkle 1, M L Stanfield 1, P Holmgreen 1, M Yeargin-Allsopp 1, C Boyle 1, S L Sherman 1
PMCID: PMC1377758  PMID: 9973286

Abstract

We conducted a large population-based survey of fragile X (FRAXA) syndrome in ethnically diverse metropolitan Atlanta. The eligible study population consisted of public school children, aged 7-10 years, in special education-needs (SEN) classes. The purpose of the study was to estimate the prevalence among whites and, for the first time, African Americans, among a non-clinically referred population. At present, 5 males with FRAXA syndrome (4 whites and 1 African American), among 1,979 tested males, and no females, among 872 tested females, were identified. All males with FRAXA syndrome were mentally retarded and had been diagnosed previously. The prevalence for FRAXA syndrome was estimated to be 1/3,460 (confidence interval [CI] 1/7,143-1/1,742) for the general white male population and 1/4, 048 (CI 1/16,260-1/1,244) for the general African American male population. We also compared the frequency of intermediate and premutation FRAXA alleles (41-199 repeats) and fragile XE syndrome alleles (31-199 repeats) in the SEN population with that in a control population, to determine if there was a possible phenotype consequence of such high-repeat alleles, as has been reported previously. No difference was observed between our case and control populations, and no difference was observed between populations when the probands were grouped by a rough estimate of IQ based on class placement. These results suggest that there is no phenotype consequence of larger alleles that would cause carriers to be placed in an SEN class.

Full Text

The Full Text of this article is available as a PDF (262.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allingham-Hawkins D. J., Brown C. A., Babul R., Chitayat D., Krekewich K., Humphries T., Ray P. N., Teshima I. E. Tissue-specific methylation differences and cognitive function in fragile X premutation females. Am J Med Genet. 1996 Aug 9;64(2):329–333. doi: 10.1002/(SICI)1096-8628(19960809)64:2<329::AID-AJMG19>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
  2. Ashizawa T., Epstein H. F. Ethnic distribution of myotonic dystrophy gene. Lancet. 1991 Sep 7;338(8767):642–643. doi: 10.1016/0140-6736(91)90659-d. [DOI] [PubMed] [Google Scholar]
  3. Ashley A. E., Sherman S. L. Population dynamics of a meiotic/mitotic expansion model for the fragile X syndrome. Am J Hum Genet. 1995 Dec;57(6):1414–1425. [PMC free article] [PubMed] [Google Scholar]
  4. Ashley C. T., Jr, Wilkinson K. D., Reines D., Warren S. T. FMR1 protein: conserved RNP family domains and selective RNA binding. Science. 1993 Oct 22;262(5133):563–566. doi: 10.1126/science.7692601. [DOI] [PubMed] [Google Scholar]
  5. Barnicoat A. J., Wang Q., Turk J., Green E., Mathew C. G., Flynn G., Buckle V., Hirst M., Davies K., Bobrow M. Clinical, cytogenetic, and molecular analysis of three families with FRAXE. J Med Genet. 1997 Jan;34(1):13–17. doi: 10.1136/jmg.34.1.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Biancalana V., Taine L., Bouix J. C., Finck S., Chauvin A., De Verneuil H., Knight S. J., Stoll C., Lacombe D., Mandel J. L. Expansion and methylation status at FRAXE can be detected on EcoRI blots used for FRAXA diagnosis: analysis of four FRAXE families with mild mental retardation in males. Am J Hum Genet. 1996 Oct;59(4):847–854. [PMC free article] [PubMed] [Google Scholar]
  7. Brown W. T., Houck G. E., Jr, Jeziorowska A., Levinson F. N., Ding X., Dobkin C., Zhong N., Henderson J., Brooks S. S., Jenkins E. C. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA. 1993 Oct 6;270(13):1569–1575. [PubMed] [Google Scholar]
  8. Brown W. T. The FRAXE Syndrome: is it time for routine screening? Am J Hum Genet. 1996 May;58(5):903–905. [PMC free article] [PubMed] [Google Scholar]
  9. Conway G. S., Hettiarachchi S., Murray A., Jacobs P. A. Fragile X premutations in familial premature ovarian failure. Lancet. 1995 Jul 29;346(8970):309–310. doi: 10.1016/s0140-6736(95)92194-x. [DOI] [PubMed] [Google Scholar]
  10. Conway G. S., Payne N. N., Webb J., Murray A., Jacobs P. A. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod. 1998 May;13(5):1184–1187. doi: 10.1093/humrep/13.5.1184. [DOI] [PubMed] [Google Scholar]
  11. Cronister A., Schreiner R., Wittenberger M., Amiri K., Harris K., Hagerman R. J. Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic features. Am J Med Genet. 1991 Feb-Mar;38(2-3):269–274. doi: 10.1002/ajmg.1320380221. [DOI] [PubMed] [Google Scholar]
  12. Dawson A. J., Chodirker B. N., Chudley A. E. Frequency of FMR1 premutations in a consecutive newborn population by PCR screening of Guthrie blood spots. Biochem Mol Med. 1995 Oct;56(1):63–69. doi: 10.1006/bmme.1995.1057. [DOI] [PubMed] [Google Scholar]
  13. Deissler H., Behn-Krappa A., Doerfler W. Purification of nuclear proteins from human HeLa cells that bind specifically to the unstable tandem repeat (CGG)n in the human FMR1 gene. J Biol Chem. 1996 Feb 23;271(8):4327–4334. doi: 10.1074/jbc.271.8.4327. [DOI] [PubMed] [Google Scholar]
  14. Dennis N. R., Curtis G., Macpherson J. N., Jacobs P. A. Two families with Xq27.3 fragility, no detectable insert in the FMR-1 gene, mild mental impairment, and absence of the Martin-Bell phenotype. 1992 Apr 15-May 1Am J Med Genet. 43(1-2):232–236. doi: 10.1002/ajmg.1320430137. [DOI] [PubMed] [Google Scholar]
  15. Elbaz A., Suédois J., Duquesnoy M., Beldjord C., Berchel C., Mérault G. Prevalence of fragile-X syndrome and FRAXE among children with intellectual disability in a Caribbean island, Guadeloupe, French West Indies. J Intellect Disabil Res. 1998 Feb;42(Pt 1):81–89. doi: 10.1046/j.1365-2788.1998.00064.x. [DOI] [PubMed] [Google Scholar]
  16. Feng Y., Lakkis L., Devys D., Warren S. T. Quantitative comparison of FMR1 gene expression in normal and premutation alleles. Am J Hum Genet. 1995 Jan;56(1):106–113. [PMC free article] [PubMed] [Google Scholar]
  17. Flynn G. A., Hirst M. C., Knight S. J., Macpherson J. N., Barber J. C., Flannery A. V., Davies K. E., Buckle V. J. Identification of the FRAXE fragile site in two families ascertained for X linked mental retardation. J Med Genet. 1993 Feb;30(2):97–100. doi: 10.1136/jmg.30.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Franke P., Maier W., Hautzinger M., Weiffenbach O., Gänsicke M., Iwers B., Poustka F., Schwab S. G., Froster U. Fragile-X carrier females: evidence for a distinct psychopathological phenotype? Am J Med Genet. 1996 Aug 9;64(2):334–339. doi: 10.1002/(SICI)1096-8628(19960809)64:2<334::AID-AJMG20>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  19. Fu Y. H., Kuhl D. P., Pizzuti A., Pieretti M., Sutcliffe J. S., Richards S., Verkerk A. J., Holden J. J., Fenwick R. G., Jr, Warren S. T. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991 Dec 20;67(6):1047–1058. doi: 10.1016/0092-8674(91)90283-5. [DOI] [PubMed] [Google Scholar]
  20. Goldman A., Krause A., Jenkins T. Fragile X syndrome occurs in the South African black population. S Afr Med J. 1997 Apr;87(4):418–420. [PubMed] [Google Scholar]
  21. Goldman A., Ramsay M., Jenkins T. Absence of myotonic dystrophy in southern African Negroids is associated with a significantly lower number of CTG trinucleotide repeats. J Med Genet. 1994 Jan;31(1):37–40. doi: 10.1136/jmg.31.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Gécz J., Oostra B. A., Hockey A., Carbonell P., Turner G., Haan E. A., Sutherland G. R., Mulley J. C. FMR2 expression in families with FRAXE mental retardation. Hum Mol Genet. 1997 Mar;6(3):435–441. doi: 10.1093/hmg/6.3.435. [DOI] [PubMed] [Google Scholar]
  23. Hagerman R. J., Amiri K., Cronister A. Fragile X checklist. Am J Med Genet. 1991 Feb-Mar;38(2-3):283–287. doi: 10.1002/ajmg.1320380223. [DOI] [PubMed] [Google Scholar]
  24. Hagerman R. J. Annotation: fragile X syndrome: advances and controversy. J Child Psychol Psychiatry. 1992 Oct;33(7):1127–1139. doi: 10.1111/j.1469-7610.1992.tb00933.x. [DOI] [PubMed] [Google Scholar]
  25. Hamel B. C., Smits A. P., de Graaff E., Smeets D. F., Schoute F., Eussen B. H., Knight S. J., Davies K. E., Assman-Hulsmans C. F., Oostra B. A. Segregation of FRAXE in a large family: clinical, psychometric, cytogenetic, and molecular data. Am J Hum Genet. 1994 Nov;55(5):923–931. [PMC free article] [PubMed] [Google Scholar]
  26. Hećimović S., Barisić I., Müller A., Petković I., Barić I., Ligutić I., Pavelić K. Expand Long PCR for fragile X mutation detection. Clin Genet. 1997 Sep;52(3):147–154. doi: 10.1111/j.1399-0004.1997.tb02535.x. [DOI] [PubMed] [Google Scholar]
  27. Howard-Peebles P. N., Stoddard G. R. Race distribution in X-linked mental retardation with macro-orchidism and fragile site in Xq. Am J Hum Genet. 1980 Jul;32(4):629–630. [PMC free article] [PubMed] [Google Scholar]
  28. Hull C., Hagerman R. J. A study of the physical, behavioral, and medical phenotype, including anthropometric measures, of females with fragile X syndrome. Am J Dis Child. 1993 Nov;147(11):1236–1241. doi: 10.1001/archpedi.1993.02160350110017. [DOI] [PubMed] [Google Scholar]
  29. Knight S. J., Flannery A. V., Hirst M. C., Campbell L., Christodoulou Z., Phelps S. R., Pointon J., Middleton-Price H. R., Barnicoat A., Pembrey M. E. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell. 1993 Jul 16;74(1):127–134. doi: 10.1016/0092-8674(93)90300-f. [DOI] [PubMed] [Google Scholar]
  30. Knight S. J., Ritchie R. J., Chakrabarti L., Cross G., Taylor G. R., Mueller R. F., Hurst J., Paterson J., Yates J. R., Dow D. J. A study of FRAXE in mentally retarded individuals referred for fragile X syndrome (FRAXA) testing in the United Kingdom. Am J Hum Genet. 1996 May;58(5):906–913. [PMC free article] [PubMed] [Google Scholar]
  31. Kolehmainen K. Population genetics of fragile X: a multiple allele model with variable risk of CGG repeat expansion. Am J Med Genet. 1994 Jul 15;51(4):428–435. doi: 10.1002/ajmg.1320510425. [DOI] [PubMed] [Google Scholar]
  32. Kunst C. B., Warren S. T. Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles. Cell. 1994 Jun 17;77(6):853–861. doi: 10.1016/0092-8674(94)90134-1. [DOI] [PubMed] [Google Scholar]
  33. Loesch D. Z., Hay D. A., Mulley J. Transmitting males and carrier females in fragile X--revisited. Am J Med Genet. 1994 Jul 15;51(4):392–399. doi: 10.1002/ajmg.1320510418. [DOI] [PubMed] [Google Scholar]
  34. Mazzocco M. M., Pennington B. F., Hagerman R. J. The neurocognitive phenotype of female carriers of fragile X: additional evidence for specificity. J Dev Behav Pediatr. 1993 Oct;14(5):328–335. [PubMed] [Google Scholar]
  35. Mazzocco M. M., Sonna N. L., Teisl J. T., Pinit A., Shapiro B. K., Shah N., Reiss A. L. The FMR1 and FMR2 mutations are not common etiologies of academic difficulty among school-age children. J Dev Behav Pediatr. 1997 Dec;18(6):392–398. doi: 10.1097/00004703-199712000-00004. [DOI] [PubMed] [Google Scholar]
  36. McCartney K., Harris M. J., Bernieri F. Growing up and growing apart: a developmental meta-analysis of twin studies. Psychol Bull. 1990 Mar;107(2):226–237. doi: 10.1037/0033-2909.107.2.226. [DOI] [PubMed] [Google Scholar]
  37. McConkie-Rosell A., Lachiewicz A. M., Spiridigliozzi G. A., Tarleton J., Schoenwald S., Phelan M. C., Goonewardena P., Ding X., Brown W. T. Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome. Am J Hum Genet. 1993 Oct;53(4):800–809. [PMC free article] [PubMed] [Google Scholar]
  38. Meadows K. L., Pettay D., Newman J., Hersey J., Ashley A. E., Sherman S. L. Survey of the fragile X syndrome and the fragile X E syndrome in a special education needs population. Am J Med Genet. 1996 Aug 9;64(2):428–433. doi: 10.1002/(SICI)1096-8628(19960809)64:2<428::AID-AJMG39>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  39. Mornet E., Chateau C., Simon-Bouy B., Serre J. L. The intermediate alleles of the fragile X CGG repeat in patients with mental retardation. Clin Genet. 1998 Mar;53(3):200–201. doi: 10.1111/j.1399-0004.1998.tb02676.x. [DOI] [PubMed] [Google Scholar]
  40. Morris A., Morton N. E., Collins A., Lawrence S., Macpherson J. N. Evolutionary dynamics of the FMR1 locus. Ann Hum Genet. 1995 Jul;59(Pt 3):283–289. doi: 10.1111/j.1469-1809.1995.tb00748.x. [DOI] [PubMed] [Google Scholar]
  41. Morris A., Morton N. E., Collins A., Macpherson J., Nelson D., Sherman S. An n-allele model for progressive amplification in the FMR1 locus. Proc Natl Acad Sci U S A. 1995 May 23;92(11):4833–4837. doi: 10.1073/pnas.92.11.4833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Morton J. E., Bundey S., Webb T. P., MacDonald F., Rindl P. M., Bullock S. Fragile X syndrome is less common than previously estimated. J Med Genet. 1997 Jan;34(1):1–5. doi: 10.1136/jmg.34.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Morton N. E., Macpherson J. N. Population genetics of the fragile-X syndrome: multiallelic model for the FMR1 locus. Proc Natl Acad Sci U S A. 1992 May 1;89(9):4215–4217. doi: 10.1073/pnas.89.9.4215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Mulley J. C., Yu S., Loesch D. Z., Hay D. A., Donnelly A., Gedeon A. K., Carbonell P., López I., Glover G., Gabarrón I. FRAXE and mental retardation. J Med Genet. 1995 Mar;32(3):162–169. doi: 10.1136/jmg.32.3.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Murray A., Webb J., Grimley S., Conway G., Jacobs P. Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet. 1998 Aug;35(8):637–640. doi: 10.1136/jmg.35.8.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Murray A., Youings S., Dennis N., Latsky L., Linehan P., McKechnie N., Macpherson J., Pound M., Jacobs P. Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mothers. Hum Mol Genet. 1996 Jun;5(6):727–735. doi: 10.1093/hmg/5.6.727. [DOI] [PubMed] [Google Scholar]
  47. Nolin S. L., Lewis F. A., 3rd, Ye L. L., Houck G. E., Jr, Glicksman A. E., Limprasert P., Li S. Y., Zhong N., Ashley A. E., Feingold E. Familial transmission of the FMR1 CGG repeat. Am J Hum Genet. 1996 Dec;59(6):1252–1261. [PMC free article] [PubMed] [Google Scholar]
  48. Partington M. W., Moore D. Y., Turner G. M. Confirmation of early menopause in fragile X carriers. Am J Med Genet. 1996 Aug 9;64(2):370–372. doi: 10.1002/(SICI)1096-8628(19960809)64:2<370::AID-AJMG27>3.0.CO;2-B. [DOI] [PubMed] [Google Scholar]
  49. Philips A. V., Timchenko L. T., Cooper T. A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science. 1998 May 1;280(5364):737–741. doi: 10.1126/science.280.5364.737. [DOI] [PubMed] [Google Scholar]
  50. Pieretti M., Zhang F. P., Fu Y. H., Warren S. T., Oostra B. A., Caskey C. T., Nelson D. L. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991 Aug 23;66(4):817–822. doi: 10.1016/0092-8674(91)90125-i. [DOI] [PubMed] [Google Scholar]
  51. Reiss A. L., Freund L., Abrams M. T., Boehm C., Kazazian H. Neurobehavioral effects of the fragile X premutation in adult women: a controlled study. Am J Hum Genet. 1993 May;52(5):884–894. [PMC free article] [PubMed] [Google Scholar]
  52. Riddle J. E., Cheema A., Sobesky W. E., Gardner S. C., Taylor A. K., Pennington B. F., Hagerman R. J. Phenotypic involvement in females with the FMR1 gene mutation. Am J Ment Retard. 1998 May;102(6):590–601. doi: 10.1352/0895-8017(1998)102<0590:piifwt>2.0.co;2. [DOI] [PubMed] [Google Scholar]
  53. Rousseau F., Heitz D., Tarleton J., MacPherson J., Malmgren H., Dahl N., Barnicoat A., Mathew C., Mornet E., Tejada I. A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases. Am J Hum Genet. 1994 Aug;55(2):225–237. [PMC free article] [PubMed] [Google Scholar]
  54. Rousseau F., Rouillard P., Morel M. L., Khandjian E. W., Morgan K. Prevalence of carriers of premutation-size alleles of the FMRI gene--and implications for the population genetics of the fragile X syndrome. Am J Hum Genet. 1995 Nov;57(5):1006–1018. [PMC free article] [PubMed] [Google Scholar]
  55. Schwartz C. E., Dean J., Howard-Peebles P. N., Bugge M., Mikkelsen M., Tommerup N., Hull C., Hagerman R., Holden J. J., Stevenson R. E. Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am J Med Genet. 1994 Jul 15;51(4):400–402. doi: 10.1002/ajmg.1320510419. [DOI] [PubMed] [Google Scholar]
  56. Spence W. C., Black S. H., Fallon L., Maddalena A., Cummings E., Menapace-Drew G., Bick D. P., Levinson G., Schulman J. D., Howard-Peebles P. N. Molecular fragile X screening in normal populations. Am J Med Genet. 1996 Jul 12;64(1):181–183. doi: 10.1002/(SICI)1096-8628(19960712)64:1<181::AID-AJMG31>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
  57. Sutcliffe J. S., Nelson D. L., Zhang F., Pieretti M., Caskey C. T., Saxe D., Warren S. T. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet. 1992 Sep;1(6):397–400. doi: 10.1093/hmg/1.6.397. [DOI] [PubMed] [Google Scholar]
  58. Sutherland G. R., Baker E. Characterisation of a new rare fragile site easily confused with the fragile X. Hum Mol Genet. 1992 May;1(2):111–113. doi: 10.1093/hmg/1.2.111. [DOI] [PubMed] [Google Scholar]
  59. Sved J. A., Laird C. D. Population genetic consequences of the fragile-X syndrome, based on the X-inactivation imprinting model. Am J Hum Genet. 1990 Mar;46(3):443–451. [PMC free article] [PubMed] [Google Scholar]
  60. Syrrou M., Georgiou I., Grigoriadou M., Petersen M. B., Kitsiou S., Pagoulatos G., Patsalis P. C. FRAXA and FRAXE prevalence in patients with nonspecific mental retardation in the Hellenic population. Genet Epidemiol. 1998;15(1):103–109. doi: 10.1002/(SICI)1098-2272(1998)15:1<103::AID-GEPI8>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  61. Teague J. W., Morton N. E., Dennis N. R., Curtis G., McKechnie N., Macpherson J. N., Murray A., Pound M. C., Sharrock A. J., Youings S. A. FRAXA and FRAXE: evidence against segregation distortion and for an effect of intermediate alleles on learning disability. Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):719–724. doi: 10.1073/pnas.95.2.719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Turner G., Webb T., Wake S., Robinson H. Prevalence of fragile X syndrome. Am J Med Genet. 1996 Jul 12;64(1):196–197. doi: 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  63. Venter P. A., Gericke G. S., Dawson B., Op't Hof J. A marker X chromosome associated with nonspecific male mental retardation. The first South African cases. S Afr Med J. 1981 Nov 21;60(21):807–811. [PubMed] [Google Scholar]
  64. Venter P. A., Op't Hof J. Cytogenetic abnormalities including the marker X chromosome in patients with severe mental retardation. S Afr Med J. 1982 Dec 11;62(25):947–950. [PubMed] [Google Scholar]
  65. Verkerk A. J., Pieretti M., Sutcliffe J. S., Fu Y. H., Kuhl D. P., Pizzuti A., Reiner O., Richards S., Victoria M. F., Zhang F. P. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991 May 31;65(5):905–914. doi: 10.1016/0092-8674(91)90397-h. [DOI] [PubMed] [Google Scholar]
  66. Watkins W. S., Bamshad M., Jorde L. B. Population genetics of trinucleotide repeat polymorphisms. Hum Mol Genet. 1995 Sep;4(9):1485–1491. doi: 10.1093/hmg/4.9.1485. [DOI] [PubMed] [Google Scholar]
  67. Winter R. M. Population genetics implications of the premutation hypothesis for the generation of the fragile X mental retardation gene. Hum Genet. 1987 Mar;75(3):269–271. doi: 10.1007/BF00281072. [DOI] [PubMed] [Google Scholar]
  68. Wolff P. H., Gardner J., Lappen J., Paccia J., Meryash D. Variable expression of the fragile X syndrome in heterozygous females of normal intelligence. Am J Med Genet. 1988 May-Jun;30(1-2):213–225. doi: 10.1002/ajmg.1320300121. [DOI] [PubMed] [Google Scholar]
  69. Zhong N., Ju W., Curley D., Wang D., Pietrofesa J., Wu G., Shen Y., Pang C., Poon P., Liu X. A survey of FRAXE allele sizes in three populations. Am J Med Genet. 1996 Aug 9;64(2):415–419. doi: 10.1002/(SICI)1096-8628(19960809)64:2<415::AID-AJMG36>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  70. de Vries B. B., van den Ouweland A. M., Mohkamsing S., Duivenvoorden H. J., Mol E., Gelsema K., van Rijn M., Halley D. J., Sandkuijl L. A., Oostra B. A. Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group. Am J Hum Genet. 1997 Sep;61(3):660–667. doi: 10.1086/515496. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES